“Intravenous Tocilizumab Versus Standard of Care in the Treatment of Severe and Critical COVID-19-Related Pneumonia: A Single Center, Double-Blind, Placebo Controlled, Phase 3 Trial ”. Acta Medica Philippina, vol. 58, no. 6, Apr. 2024, https://doi.org/10.47895/amp.vi0.6175.